Synthesis of the C1–C13 Fragment of Eribulin on a Kilogram Scale-Reference-Cited by-同舟云学术

Synthesis of the C1–C13 Fragment of Eribulin on a Kilogram Scale

Published:2021-12-14 Issue:1 Volume:26 Page:123-128
ISSN:1083-6160
Container-title:Organic Process Research & Development
language:en
Short-container-title:Org. Process Res. Dev.

Author:

Kim Seong Taek¹,Park Yongseo¹,Kim Namhyeon¹,Gu Jaeun¹,Son Wongyoung¹,Hur Jisu¹,Lee KangHee¹,Baek Areum¹,Song Ju Young¹,Kim U Bin¹,Lee Kee-Young¹,Oh Chang-Young¹,Park Seokhwi¹^ORCID,Shin Hyunik¹^ORCID

Affiliation:

1. R&D Center, Yonsung Fine Chemicals Company Limited, Innoplex-2-dong, 306, Sinwon-ro, Yeongtong-gu, Suwon-si 16675, Gyeonggi-do, Republic of Korea

Funder

Ministry of Trade, Industry and Energy

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.oprd.1c00295

Reference21 articles.

1. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

2. Eribulin mesylate: A novel halichondrin B analogue for the treatment of metastatic breast cancer

3. Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer

4. FDA Approval Summary: Eribulin for Patients with Unresectable or Metastatic Liposarcoma Who Have Received a Prior Anthracycline-Containing Regimen

5. Perspectives on the mechanism of action and clinical application of eribulin for metastatic breast cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proprietary Synthesis of the C27–C35 Fragment of Eribulin and Its Elaboration toward the C14–C35 Subunit;Organic Process Research & Development;2024-06-28

2. Comprehensive review on the elaboration of payloads derived from natural products for antibody-drug conjugates;European Journal of Medicinal Chemistry;2024-03

3. Scalable synthesis of the C14–C23 fragment of Eribulin and Halichondrin B;Bulletin of the Korean Chemical Society;2022-09-27

4. Synthesis of the C1–C13 Fragment of Eribulin;Synfacts;2022-03-18